Live Breaking News & Updates on Stony Brookny Neurosciences Institute

Stay updated with breaking news from Stony brookny neurosciences institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ublituximab Bests Teriflunomide for MS in Two Phase 3 Trials

Ublituximab is superior to teriflunomide in suppressing multiple sclerosis relapses and lesions on MRI, suggest findings from the phase 3 ULTIMATE I and II trials. ....

Lawrence Steinman , Viela Bio , Genentech Roche , Patricia Coyle , Sanofi Genzyme , Stanford Calif University , Ms Comprehensive Care Center , Bristol Myers Squibb , Stony Brookny Neurosciences Institute , New England Journal , Care Center , Stony Brook , Neurosciences Institute , Multiple Sclerosis Ms , Multiple Sclerosis , Intravenous Iv , Multiple Sclerosis Relapse , S Relapse , Elapse Of Multiple Sclerosis , Elapse Of Ms , Magnetic Resonance Imaging Mri , Magnetic Resonance Imaging , Maging Magnetic Resonance , Alignant Neoplasia , Heat Exhaustion , Heat Prostration ,